Revance Therapeutics, Inc.
RVNCDelisted Feb 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479290
Revance Therapeutics, Inc. was delisted on Feb 6, 2025; its insiders filed their last Form 4 on Feb 6, 2025; 174 institutions reported holding it in 13F filings for Q4 2024, worth $249.2M in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Revance Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
RVNC is no longer listed, so this page shows Q4 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 174
- −26 vs. Q3 2024
- Shares held
- 82.0M
- −909.4K (−1.1%) vs. Q3 2024
- Total value
- $249.2M
- −$180.7M (−42.0%) vs. Q3 2024
- New holders
- 33
- 60 more added
- Sold out
- 59
- 50 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVNC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $425.0K |
| Q4 2024 | 174 | $249.2M |
| Q3 2024 | 201 | $429.9M |
| Q2 2024 | 173 | $209.3M |
| Q1 2024 | 188 | $409.4M |
| Q4 2023 | 193 | $636.4M |
| Q3 2023 | 187 | $893.1M |
| Q2 2023 | 215 | $2.07B |
| Q1 2023 | 217 | $2.46B |
| Q4 2022 | 193 | $1.36B |
| Q3 2022 | 182 | $1.82B |
| Q2 2022 | 161 | $774.3M |
| Q1 2022 | 156 | $1.06B |
| Q4 2021 | 151 | $864.7M |
| Q3 2021 | 159 | $1.53B |
| Q2 2021 | 161 | $1.60B |
| Q1 2021 | 149 | $1.53B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Revance Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −30,100−100.0% | Sold out |
| Knott David M Jr | 0 | $0 | 0.00% | −31,355−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −27,381−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −25,469−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,129−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −20,819−100.0% | Sold out |
| DCF Advisers, LLC | 0 | $0 | 0.00% | −19,417−100.0% | Sold out |
| Freestone Capital Holdings, LLC | 0 | $0 | 0.00% | −18,020−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −17,001−100.0% | Sold out |
| Daymark Wealth Partners, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Accredited Investors Inc. | 0 | $0 | 0.00% | −12,845−100.0% | Sold out |
| Sargent Investment Group, LLC | 0 | $0 | 0.00% | −12,732−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −11,655−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −11,306−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −10,278−100.0% | Sold out |
| Camden Capital, LLC | 0 | $0 | 0.00% | −10,263−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −7,276−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −7,102−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −3,794−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −3,049−100.0% | Sold out |
| Future Financial Wealth Managment LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −434−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −412−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −364−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Naples Money Management LLC | – | – | – | – | Not filed |